David Michels

David Michels received his PhD in analytical chemistry from University of Washington under the advisory of Dr. Norman Dovichi, and his post-doctoral fellowship from the analytical sciences department at Amgen, Seattle under the guidance of Dr. Alain Balland, where he developed new derivatization schemes with fluorescent labels for antibody characterization of closely related recombinant protein variants using capillary electrophoresis (CE) technology. In 2007, David joined Genentech as a scientist and has since, held several positions of increasing responsibilities. He is currently a principal scientist and senior group leader in the department of protein analytical chemistry. His current primary responsibilities include holding several leadership roles as a characterization scientist and for control system strategies for early and late-stage projects, and the primary subject matter expert for CE and microchip technologies in managing the development of innovative CE-based methodologies for supporting process development, protein characterization and quality control (QC) lot release testing of clinical and commercial products.

David is the author/co-author of over 15 scientific peer-reviewed publications in the field of analytical science and biotechnology. David also serves as a member of the CASSS Associate Directors and CASSS committee member and chair of the “International Symposium of CE in the Pharmaceutical and Biotechnology Industries (CE Pharm)”.